CJC-1295 DAC HORMONE IN VIALS

CJC-1295 DAC — research GHRH analogue

CJC-1295 with DAC is a long-acting growth-hormone-releasing hormone analogue, studied for how it extends GH-axis signalling over an extended window — the DAC modification is what gives it its long half-life relative to the standard peptide. That durability is its defining feature. HelixaMed supplies it lyophilised and lab-verified for identity and concentration.

It is frequently researched together with a GHRP such as ipamorelin, and like all peptides it is delicate: freeze-dried on arrival, reconstituted with bacteriostatic water and stored cold. Our reconstitution guide covers correct handling so a study runs on stable material. Sold strictly as a research compound; no dosing or human-use guidance is provided.

• Long-acting: the DAC modification extends its half-life.
• Often paired: researched alongside a GHRP.
• Verified: lyophilised vial with batch analysis.